C. V. Dang
Molecular Biology · 2000–2017
A researcher in the Science corpus: 30 papers; trusts 72 researchers and is trusted by 86 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 507 citations into it; #333 of 17,836 by trust here, #524 by citations
- Cancer Research — 384 citations into it; #27 of 1,784 by trust here, #43 by citations
- Oncology — 97 citations into it; #820 of 1,698 by trust here, #378 by citations
- Genetics — 60 citations into it; #5,716 of 6,875 by trust here, #892 by citations
- Physiology — 47 citations into it
- Cell Biology — 43 citations into it; #771 of 2,073 by trust here, #129 by citations
- Immunology — 40 citations into it
- Biochemistry — 30 citations into it
Whom C. V. Dang trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Jung-whan Kim
- G. Semenza
- Ralph J. Deberardinis
- A. Le
- V. Fantin
- M. V. Vander Heiden
- Ping Gao
- David R. Wise
- Jan van Riggelen
- R. Scarpulla
Who trusts C. V. Dang overall
- Maria Liberti
- Ralph J. Deberardinis
- C. Hensley
- C. Folmes
- G. Semenza
- D. Fruman
- P. Vaupel
- Jason W. Locasale
- Charles Y. Lin
- Jie Zheng
Papers from C. V. Dang's perspective
Ordered by how strongly the researchers C. V. Dang trusts endorse each paper. Same corpus, a different order for every researcher.
- c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism (Nature)
- Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis (Molecular and Cellular Biology)
- Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. (Cancer Cell)
- Why do cancers have high aerobic glycolysis? (Nature Reviews. Cancer)
- Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc* (Journal of Biological Chemistry)
- HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. (Cell Metabolism)
- Transcriptional regulation and transformation by Myc proteins (Nature reviews. Molecular cell biology)
- The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. (Cell Metabolism)
- Targeting HIF-1 for cancer therapy (Nature Reviews. Cancer)
- Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. (Cell Metabolism)
Their papers
- HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. (2006) — 3,822 citations
- Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc* (2000) — 879 citations
- Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis (2005) — 629 citations
- HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. (2007) — 907 citations
- Development of human protein reference database as an initial platform for approaching systems biology in humans. (2003) — 1,149 citations
- MYC on the Path to Cancer (2012) — 3,217 citations
- Widespread microRNA repression by Myc contributes to tumorigenesis (2008) — 1,395 citations
- Targeting mitochondrial glutaminase activity inhibits oncogenic transformation (2010) — 824 citations
- Cancer's molecular sweet tooth and the Warburg effect. (2006) — 1,250 citations
- The c-Myc target gene network. (2006) — 1,191 citations
- Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression (2010) — 1,477 citations
- Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B-cells (2012) — 1,071 citations
- Otto Warburg's contributions to current concepts of cancer metabolism (2011) — 1,461 citations
- Otto Warburg's contributions to current concepts of cancer metabolism (2011) — 2,249 citations
- Links between metabolism and cancer. (2012) — 1,006 citations
- Multifaceted roles of glycolytic enzymes. (2005) — 702 citations
- MYC-induced Cancer Cell Energy Metabolism and Therapeutic Opportunities (2009) — 895 citations
- Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1 (2007) — 628 citations
- Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth (2008) — 623 citations
- MYC, Metabolism, and Cancer. (2015) — 1,111 citations